Sr One Capital Partners I, Lp - Net Worth and Insider Trading

Over the past 18 months, Sr One Capital Partners I, Lp made no insider transaction in Arcellx Inc (ACLX). Other recent insider transactions involving Arcellx Inc (ACLX) include a net sale of 343,050 shares made by Christopher Heery , a net sale of 76,479 shares made by Kavita Patel , and a net sale of 82,395 shares made by Michelle Gilson .

In summary, during the past 3 months, insiders sold 148,839 shares of Arcellx Inc (ACLX) in total and bought 0 shares, with a net sale of 148,839 shares. During the past 18 months, 1,962,396 shares of Arcellx Inc (ACLX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,962,396 shares.

Arcellx Inc (ACLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Sr One Capital Partners I, Lp made no insider transaction in Design Therapeutics Inc (DSGN). Other recent insider transactions involving Design Therapeutics Inc (DSGN) include a net purchase of 1,420,126 shares made by Arsani William , a net purchase of 26,965 shares made by John P. Schmid , and a net purchase of 21,000 shares made by Rodney W Lappe .

In summary, during the past 3 months, insiders sold 0 shares of Design Therapeutics Inc (DSGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 814,874 shares of Design Therapeutics Inc (DSGN) were sold and 2,296,265 shares were bought by its insiders, resulting in a net purchase of 1,481,391 shares.

Design Therapeutics Inc (DSGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Sr One Capital Partners I, Lp made no insider transaction in eFFECTOR Therapeutics Inc (EFTR). Other recent insider transactions involving eFFECTOR Therapeutics Inc (EFTR) include a net sale of 609,163 shares made by Sr One Capital Fund I Aggregator Lp ,

In summary, during the past 3 months, insiders sold 0 shares of eFFECTOR Therapeutics Inc (EFTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,367 shares of eFFECTOR Therapeutics Inc (EFTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 24,367 shares.

eFFECTOR Therapeutics Inc (EFTR)'s detailed insider trading history can be found in Insider Trading Tracker table.